Kryger Capital’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Kryger Capital’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-880,756	Closed	-$40.9M	–	18
2023 Q2	$40.9M	Buy	+880,756	New	+$30.4M	4.19%	13

Kryger Capital's DICE Position: Q3 2023 in Review

Kryger Capital sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 880,756 shares — an estimated $40.9M sold.

Kryger Capital first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $40.9M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Kryger Capital reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Kryger Capital sold 880,756 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $40.9M.
Kryger Capital first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Kryger Capital's DICE Therapeutics, Inc. Common Stock position peaked at $40.9M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Kryger Capital's 13F filing for Q3 2023, filed 14 Nov 2023.